256 related articles for article (PubMed ID: 20864316)
1. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
Iizuka M; Wakamatsu E; Tsuboi H; Nakamura Y; Hayashi T; Matsui M; Goto D; Ito S; Matsumoto I; Sumida T
J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
[TBL] [Abstract][Full Text] [Related]
2. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Nakamura Y; Matsumoto I
Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
[TBL] [Abstract][Full Text] [Related]
3. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
[TBL] [Abstract][Full Text] [Related]
4. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
5. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
Asashima H; Tsuboi H; Takahashi H; Hirota T; Iizuka M; Kondo Y; Matsui M; Matsumoto I; Sumida T
Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome.
Sumida T; Iizuka M; Asashima H; Tsuboi H; Matsumoto I
Presse Med; 2012 Sep; 41(9 Pt 2):e461-6. PubMed ID: 22884125
[TBL] [Abstract][Full Text] [Related]
7. Role of immune response to M3 muscarinic acethylcholine receptor in the pathogenesis of Sjögren's syndrome.
Iizuka M; Wakamatsu E; Matsumoto I; Tsuboi H; Nakamura Y; Matsui M; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):87-91. PubMed ID: 20453444
[TBL] [Abstract][Full Text] [Related]
8. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
Schegg V; Vogel M; Didichenko S; Stadler MB; Beleznay Z; Gadola S; Sengupta C; Stadler BM; Miescher SM
Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
[TBL] [Abstract][Full Text] [Related]
9. Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren's syndrome.
Kudo H; Tsuboi H; Asashima H; Takahashi H; Ono Y; Abe S; Honda F; Kondo Y; Wakasa Y; Takaiwa F; Takano M; Matsui M; Matsumoto I; Sumida T
Mod Rheumatol; 2020 Sep; 30(5):884-893. PubMed ID: 31490711
[No Abstract] [Full Text] [Related]
10. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.
Gao J; Cha S; Jonsson R; Opalko J; Peck AB
Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
[TBL] [Abstract][Full Text] [Related]
13. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Asashima H; Matsumoto I
Mod Rheumatol; 2013 Sep; 23(5):841-5. PubMed ID: 23135882
[TBL] [Abstract][Full Text] [Related]
14. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome.
Cavill D; Waterman SA; Gordon TP
Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576
[TBL] [Abstract][Full Text] [Related]
15. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
[TBL] [Abstract][Full Text] [Related]
16. [Anti-M3 muscarinic acetylcholine receptor antibodies and Sjögren's syndrome].
Tsuboi H; Iizuka M; Asashima H; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):77-85. PubMed ID: 23629427
[TBL] [Abstract][Full Text] [Related]
17. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
Wang F; Jackson MW; Maughan V; Cavill D; Smith AJ; Waterman SA; Gordon TP
Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
[TBL] [Abstract][Full Text] [Related]
18. Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor.
Tsuboi H; Nakamura Y; Iizuka M; Matsuo N; Matsumoto I; Sumida T
Mod Rheumatol; 2012 Apr; 22(2):264-71. PubMed ID: 21877253
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome].
Tsuboi H; Matsuo N; Iizuka M; Nakamura Y; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(4):222-8. PubMed ID: 20818151
[TBL] [Abstract][Full Text] [Related]
20. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Tsuboi H; Matsumoto I; Wakamatsu E; Nakamura Y; Iizuka M; Hayashi T; Goto D; Ito S; Sumida T
Clin Exp Immunol; 2010 Oct; 162(1):53-61. PubMed ID: 20731676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
